Total Payments
$2,416
2024 Payments
$173.00
Companies
26
Transactions
126
Medicare Patients
2,975
Medicare Billing
$92,736
Payment Breakdown by Category
Food & Beverage$2,273 (94.1%)
Education$142.94 (5.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,273 | 122 | 94.1% |
| Education | $142.94 | 4 | 5.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $669.61 | 28 | $0 (2024) |
| AbbVie Inc. | $332.45 | 18 | $0 (2023) |
| PFIZER INC. | $188.11 | 12 | $0 (2023) |
| Hologic, LLC | $135.93 | 6 | $0 (2022) |
| Exeltis, USA Inc. | $120.98 | 6 | $0 (2024) |
| Avion Pharmaceuticals | $112.60 | 8 | $0 (2022) |
| Allergan, Inc. | $98.70 | 7 | $0 (2020) |
| Myovant Sciences Inc. | $87.43 | 5 | $0 (2022) |
| Sumitomo Pharma America, Inc. | $73.59 | 4 | $0 (2024) |
| CooperSurgical, Inc. | $65.61 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $173.00 | 8 | Astellas Pharma US Inc ($94.34) |
| 2023 | $521.38 | 21 | Astellas Pharma US Inc ($178.32) |
| 2022 | $493.46 | 26 | ABBVIE INC. ($111.33) |
| 2021 | $44.97 | 2 | PFIZER INC. ($44.97) |
| 2020 | $122.09 | 8 | Avion Pharmaceuticals ($39.80) |
| 2019 | $373.31 | 20 | Astellas Pharma US Inc ($102.22) |
| 2018 | $346.17 | 20 | Astellas Pharma US Inc ($113.60) |
| 2017 | $342.05 | 21 | Astellas Pharma US Inc ($116.35) |
All Payment Transactions
126 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $19.14 | General |
| 07/22/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), GARDASIL 9 | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: VACCINE | ||||||
| 07/17/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $29.99 | General |
| Category: Biological | ||||||
| 05/21/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: HORMONE THERAPY | ||||||
| 05/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Biological | ||||||
| 04/22/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Biological | ||||||
| 01/22/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $26.54 | General |
| Category: Biological | ||||||
| 01/17/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $25.56 | General |
| Category: CONTRACEPTIVE | ||||||
| 11/09/2023 | Hologic Sales and Service, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: Diagnostics | ||||||
| 11/01/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: HORMONE THERAPY | ||||||
| 10/11/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Biological | ||||||
| 09/20/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Urology | ||||||
| 09/11/2023 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Oral Contraceptive | ||||||
| 08/16/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Biological | ||||||
| 08/11/2023 | CooperSurgical, Inc. | Endosee (Device) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: Obstetrics/Gynecology (Women's Health) | ||||||
| 06/21/2023 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: Oral Contraceptive | ||||||
| 05/23/2023 | PFIZER INC. | PREMARIN (Drug), MYFEMBREE, PAXLOVID | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: WOMENS HEALTH | ||||||
| 05/22/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: HORMONE THERAPY | ||||||
| 05/15/2023 | AbbVie Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $30.54 | General |
| Category: WOMENS HEALTH | ||||||
| 05/10/2023 | Exeltis, USA Inc. | TYBLUME (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Oral Contraceptive | ||||||
| 04/17/2023 | AbbVie Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $27.89 | General |
| Category: WOMENS HEALTH | ||||||
| 03/29/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: HORMONE THERAPY | ||||||
| 03/28/2023 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.99 | General |
| 03/14/2023 | AbbVie Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: WOMENS HEALTH | ||||||
| 03/04/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 777 | 793 | $54,743 | $24,549 |
| 2022 | 7 | 707 | 720 | $43,877 | $21,657 |
| 2021 | 9 | 814 | 841 | $55,546 | $27,537 |
| 2020 | 7 | 677 | 694 | $41,269 | $18,992 |
Total Patients
2,975
Total Services
3,048
Medicare Billing
$92,736
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 74 | 82 | $19,670 | $7,135 | 36.3% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 134 | 134 | $6,111 | $5,394 | 88.3% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 134 | 134 | $6,111 | $4,987 | 81.6% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2023 | 28 | 29 | $7,250 | $2,545 | 35.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 33 | $7,260 | $2,155 | 29.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 25 | 25 | $3,000 | $990.15 | 33.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 210 | 210 | $3,150 | $716.10 | 22.7% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2023 | 146 | 146 | $2,190 | $626.34 | 28.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 85 | 90 | $19,800 | $8,235 | 41.6% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 124 | 124 | $4,739 | $4,669 | 98.5% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 122 | 122 | $4,663 | $4,595 | 98.5% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2022 | 25 | 26 | $6,500 | $2,171 | 33.4% |
| 81002 | Urinalysis, manual test | Office | 2022 | 205 | 210 | $3,150 | $719.58 | 22.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 17 | $3,060 | $703.80 | 23.0% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2022 | 131 | 131 | $1,965 | $564.79 | 28.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 94 | 95 | $20,900 | $8,417 | 40.3% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 146 | 146 | $5,580 | $5,580 | 100.0% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 143 | 143 | $5,465 | $5,465 | 100.0% |
| 76830 | Ultrasound pelvis through vagina | Office | 2021 | 30 | 31 | $7,750 | $2,853 | 36.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 16 | 21 | $3,780 | $1,404 | 37.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $2,780 | $1,329 | 47.8% |
| 76856 | Ultrasound of pelvis, complete, not pregnancy related | Office | 2021 | 13 | 13 | $3,575 | $1,037 | 29.0% |
| 81002 | Urinalysis, manual test | Office | 2021 | 221 | 241 | $3,615 | $838.68 | 23.2% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2021 | 140 | 140 | $2,100 | $613.20 | 29.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 91 | 98 | $18,455 | $6,572 | 35.6% |
About Dr. Robert Dropkin, MD
Dr. Robert Dropkin, MD is a Obstetrics & Gynecology healthcare provider based in Albany, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1730198706.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Dropkin, MD has received a total of $2,416 in payments from pharmaceutical and medical device companies, with $173.00 received in 2024. These payments were reported across 126 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($2,273).
As a Medicare-enrolled provider, Dropkin has provided services to 2,975 Medicare beneficiaries, totaling 3,048 services with total Medicare billing of $92,736. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Location Albany, NY
- Active Since 08/07/2006
- Last Updated 07/08/2010
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1730198706
Products in Payments
- Myrbetriq (Drug) $199.16
- LO LOESTRIN FE (Drug) $187.56
- MYFEMBREE (Drug) $161.02
- MYRBETRIQ (Drug) $143.50
- APTIMA (Device) $140.52
- Veozah (Drug) $139.66
- PREMARIN (Drug) $117.82
- Orilissa (Drug) $102.76
- SLYND (Drug) $100.33
- VESICARE (Drug) $87.30
- Balcoltra (Drug) $82.74
- ORIAHNN (Drug) $75.75
- PVC (Drug) $57.97
- Osphena (Drug) $46.86
- Paragard (Device) $42.22
- SOLOSEC (Drug) $38.45
- ANNOVERA (Drug) $37.63
- Femring (Drug) $33.18
- Prenate Mini (Drug) $29.86
- Bonjesta (Drug) $24.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Albany
Mr. Paul Smurda, M.d, M.D
Obstetrics & Gynecology — Payments: $29,574
Obstetrics & Gynecology $29,574
Dr. Cheryl Burack, M.d, M.D
Obstetrics & Gynecology — Payments: $16,312
Obstetrics & Gynecology $16,312
Dr. Robert Lobel, Md, MD
Obstetrics & Gynecology — Payments: $9,233
Obstetrics & Gynecology $9,233
Richard Goyer, M.d, M.D
Obstetrics & Gynecology — Payments: $8,712
Obstetrics & Gynecology $8,712
Dr. Shane Gjesdal, Md, MD
Obstetrics & Gynecology — Payments: $8,301
Obstetrics & Gynecology $8,301
Mr. Thomas Talley, M.d, M.D
Obstetrics & Gynecology — Payments: $7,445
Obstetrics & Gynecology $7,445